UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4876
Global Water Resources
GWRS
$219M
| $477K | ﹤0.01% |
36,293
+5,702
| +19% | +$71.5K |
|
4877
LCNB Corp
LCNB
$282M
| $477K | ﹤0.01% |
24,711
+6,048
| +32% | +$110K |
|
4878
Travere Therapeutics
TVTX
$5.68B
| $477K | ﹤0.01% |
33,623
-129,557
| -79% | -$1.65M |
|
|
FRTA
4879
DELISTED
Forterra, Inc
FRTA
| $477K | ﹤0.01% |
41,241
+11,417
| +38% | +$111K |
|
4880
Corbus Pharmaceuticals
CRBP
$184M
| $476K | ﹤0.01% |
2,905
+1,204
| +71% | +$178K |
|
4881
CytomX Therapeutics
CTMX
$752M
| $475K | ﹤0.01% |
57,199
-32,032
| -36% | -$216K |
|
4882
HCI Group
HCI
$2.29B
| $475K | ﹤0.01% |
10,395
+3,079
| +42% | +$136K |
|
4883
Nuveen Mortgage and Income Fund
JLS
$95M
| $474K | ﹤0.01% |
21,599
-2,290
| -10% | -$51.4K |
|
|
RVNC
4884
DELISTED
Revance Therapeutics, Inc.
RVNC
| $474K | ﹤0.01% |
29,250
+27,850
| +1,989% | +$432K |
|
4885
Equity Bancshares
EQBK
$1.06B
| $473K | ﹤0.01% |
15,311
+2,888
| +23% | +$82.6K |
|
4886
PUT
uniQure
QURE
$3.12B
| $473K | ﹤0.01% |
+6,600
| New | +$362K |
|
|
HIE
4887
DELISTED
Miller/Howard High Income Equity Fund
HIE
| $472K | ﹤0.01% |
41,930
+292
| +0.7% | +$3.33K |
|
|
CBIO
4888
Crescent Biopharma
CBIO
$620M
| $471K | ﹤0.01% |
890
+462
| +108% | +$250K |
|
4889
CALL
Air Products & Chemicals
APD
$68.9B
| $470K | ﹤0.01% |
+2,000
| New | +$451K |
|
4890
Westwood Holdings Group
WHG
$182M
| $470K | ﹤0.01% |
15,865
+4,119
| +35% | +$122K |
|
|
HOUS
4891
CALL
DELISTED
Anywhere Real Estate
HOUS
| $469K | ﹤0.01% |
+48,400
| New | +$444K |
|
4892
Kimbell Royalty Partners
KRP
$1.5B
| $469K | ﹤0.01% |
27,575
+14,143
| +105% | +$210K |
|
|
VAR
4893
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
| $469K | ﹤0.01% |
+3,300
| New | +$421K |
|
|
HONE
4894
DELISTED
HarborOne Bancorp
HONE
| $468K | ﹤0.01% |
42,589
+13,284
| +45% | +$139K |
|
4895
Sportsman's Warehouse
SPWH
$46.8M
| $468K | ﹤0.01% |
58,242
+19,089
| +49% | +$135K |
|
4896
Donnelley Financial Solutions
DFIN
$1.16B
| $466K | ﹤0.01% |
44,535
+17,532
| +65% | +$184K |
|
|
RST
4897
DELISTED
ROSETTA STONE INC
RST
| $466K | ﹤0.01% |
25,713
+11,249
| +78% | +$192K |
|
4898
SK Telecom
SKM
$12.9B
| $465K | ﹤0.01% |
12,207
-304,653
| -96% | -$11.4M |
|
|
PING
4899
DELISTED
Ping Identity Holding Corp.
PING
| $465K | ﹤0.01% |
19,137
+17,637
| +1,176% | +$338K |
|
|
GGN
4900
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$836M
| $464K | ﹤0.01% |
105,431
-164,026
| -61% | -$699K |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.